Global Interspinous Spacers Market Overview:
Interspinous spacers are proposed to stabilize or distract the adjacent lamina and/or spinous processes and restrict extension to reduce pain in individuals with lumbar spinal stenosis and neurogenic claudication. Interspinous spacers are small devices inserted between the vertebral spinous methods. Interlaminar spacers are implanted between adjacent lamina and spinous processes purportedly to provide dynamic stabilization either following decompressive surgery or as an alternative to decompressive surgery.
- Increasing Disease Incidence
- Growing Medical Expenditure
- Growing Incidence of Spinal Injuries
- Prominent Technological Advancements in Medical Sector
- Rising Awareness in the Patient Population about Benefit from Spacers Implantation
- Complications Associated With Lumbar Spinal Fusion in Older Patients
- Improving Healthcare Infrastructure in Developing Countries
- Increasing Product Approvals from Regulatory Bodies
- High Cost Related to Interspinous Spacer
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail competitive advantage through combined synergies.
Some of the key players profiled in the report are Medtronic plc (Ireland), Zimmer Biomet (United States), NuVasive, Inc. (United States), Life Spine, Inc. (United States), RTI Surgical Holdings, Inc. (United States), Vertiflex, Inc. (United States), DePuy Synthes (United States), Mikai S.p.A. (Italy), Alphatec Spine, Inc. (United States), AMEDICA Corporation (United States), LDR Holding Corporation (United States) and Stryker Corporation (United States). Analyst at AdvanceMarketAnalytics see United States Players to retain maximum share of Global Interspinous Spacers market by 2024. Considering Market by Material Used, the sub-segment i.e. Bone will boost the Interspinous Spacers market. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Interspinous Spacers market. Considering Market by Static Devices, the sub-segment i.e. X STOP will boost the Interspinous Spacers market.
United States Food and Drug Administration (FDA) - The two current interspinous/interlaminar process spacers that are FDA approved and commercially available are the coflex and Superion devices. Coflex is intended to be implanted after a decompression of the canal has been performed at the affected levels.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Interspinous Spacers market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Interspinous Spacers market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Manufacturers of Interspinous Spacer, Suppliers of Interspinous Spacer, Wholesalers, Distributors and Retailers of Interspinous Spacer, Healthcare Industry, Regulatory Bodies and Governmental Bodies.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.